Peters, Jay I MDSchool of Medicine |
|
| 4/2009 - Present | Chief, Division of Pulmonary and Critical Care Medicine | University of Texas Health Science Center at San Antonio, Medicine, San Antonio, TX |
| 1/2009 - Present | Adjunct Professor Pharmaceutics | University of Texas at Austin, Pharmacology, Austin, TX |
| 9/1996 - Present | ACLS Instructor | South Texas Veterans Healthcare System, San Antonio, TX |
| 9/1996 - Present | Chair, Cold Blue Committee | South Texas Veterans Health Care System, Medicine, San Antonio, TX |
| 9/1996 - Present | Professor | The University of Texas Health Science Center at San Antonio, Medicine, San Antonio, TX |
| 9/1996 - Present | Chair, Critical Care Committee | South Texas Veterans Health Care System, Medicine, San Antonio, TX |
| 9/1994 - Present | Medical Director | University of Texas Health Science Center at San Antonio, Department of Respiratory Therapy, San Antonio, TX |
| 8/1994 - Present | Medical Director | School of Allied Health, San Antonio, TX |
| 6/1984 - Present | Staff Physician and Staff Physician | The South Texas Veterans Healthcare System, Audie L Murphy Division, Pulmonary Diseases and Critical Care, San Antonio, TX |
| 6/1984 - Present | Assistant Foundation Scientist | Southwest Foundation for Biomedical Research, San Antonio, TX |
| Year | Degree | Discipline | Institution |
| 1983 | Postdoctoral Fellowship | Pulmonary/Critical Care/Infectious Disease (Pulmonary/Critical Care/Infectious Disease Fellowship) | Baylor College of Medicine Houston , TX |
| 1980 | Postdoctoral Fellowship | Internship and Residency (Infectious Diseases) | Baylor College of Medicine Houston , TX |
| 1980 | Residency | Chief Medical Resident (Chief Medical Resident, 7/80 - 12/80) | Baylor College of Medicine Houston , TX |
| 1976 | MD | Medicine (Alpha Omega Alpha) | Baylor College of Medicine Houston , TX |
| 1973 | BA | (Magna Cum Laude) | University of Texas at Austin Austin , TX |
| 1970 | BA | (Honors & Scholars Program) | Tulane University New Orleans , LA |
| Date | Description | Institution | # Students |
| 11/2013 - Present | Grand Rounds - Asthma 2013:Pathogenesis, Therapies and Controversies | North Shore LIJ | 100 students |
| 1/2012 - Present | Pre-Doctoral Student Supervision | University of Texas at Austin | |
| 1/2012 - Present | Pre-Doctoral Student Supervision | University of Texas at Austin | |
| 9/2008 - Present | Dilemmas in the ICU | University of Texas Health Science Center at San Antonio | 50 students |
| Medical School Ethics Presentation | |||
| 7/2006 - Present | Adv Clin Eval Skills | The University of Texas Health Science Center | |
| 7/2006 - Present | On Becoming a Doctor Foundations | The University of Texas Health Science Center | |
| 6/2006 - Present | Internal Medicine Morning Report | University of Texas Health Science Center at San Antonio | 50 students |
| Faculty discussion for daily intern and resident morning conference. | |||
| 8/2000 - Present | Medical Block Course Registratio | The University of Texas Health Science Center | |
| MS-2 Pulmonary Lecture Series: Introduction to the Diagnosis and Management of Asthma | |||
| 7/2000 - Present | Intro to Clin Medicine | The University of Texas Health Science Center | |
| Annual Pulmonary ACES Course: Pre-clinical teaching using patients with a variety of pulmonary diseases (i.e., very severe chronic obstructive pulmonary disease, pulmonary fibrosis, and/or post-lung transplant) to emphasize physical exam techniques that emphasize the identification and diagnosis of pulmonary problems. | |||
| 9/1996 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1994 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1993 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1992 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1988 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1988 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1985 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 9/1984 - Present | Post-Doctoral Student Supervision | University of Texas Health Science Center at San Antonio | |
| 7/1984 - Present | Post-Doctoral Student Supervision | The University of Texas Health Science Center at San Antonio and South TX Veterans Healthcare System | |
| 7/1984 - Present | Off Campus | The University of Texas Health Science Center | 10 students |
| Medicine Thoracic Clinic Attending, University Hospital-Downtown: 1/2 day clinic per week, 6-8 weeks, 5-6 contact hours/week. | |||
| 7/1984 - Present | Clinical Medicine | The University of Texas Health Science Center | 20 students |
| 7/1984 - Present | Clinical Chest Disease | The University of Texas Health Science Center | 10 students |
| 7/1984 - Present | Clinical Medicine II | The University of Texas Health Science Center | 10 students |
| South Texas Veterans Healthcare System, Pulmonary Clinic Attending: 1/2 day clinic per week for 16 weeks, 5-6 contact hours per week. | |||
Journal Article |
| Hung JY, Horn, Diane, Woodruff, Kathleen, Prihoda, Thomas, LeSaux, Claude, Peters JI, Tio FO, Werner SL. Colony Stimulating Factor 1 Potentiates Lung Cancer Bone Metastasis - submitted Laboratory Investigation 2013 Nov;. |
| Purvis T, Pollack M, Coalson JJ, McNeish L, Williams III RO, Peters JI. Efficacy of Tacrolimus Nanoparticles Using In Vitro Cellular Assays for Immune Function.(submitted) Respiratory & Critical Care Medicine 2013 Aug;. |
| Burks ML, Brooks EG, Hill VL, Peters JI, Wood PR. Assessing proxy reports: agreement between children with asthma and their caregivers on quality of life Ann Allergy Asthma Immunol 2013 Jul;111(1):14-19. |
| Bayer J, Das NA, Basiden CE, Rani M, Schwacha MG, Sako EY, Williams RO, Peters JI, Johnson SB. Effect of Inhaled Tacrolimus on Ischemia Reperfusion Injury in a Rat Lung Transplant Model The Journal of Thoracic and Cardiovascular Surgery 2013 May;146(5):1213-1219. |
| Wood PR, Hill VL, Burks ML, Peters JI, Singh H, Kannan TR, Vale S, Cagle MP, Principe MF, Baseman JB, Brooks EG. Mycoplasma pneumoniae in children with acute and refractory asthma Ann Allergy Asthma Immunol 2013 May;110:328-334. |
| Jagirdar J, Chikkamuniyappa, S, Sirohi, D., McCarthy MJ, Peters JI. Cystic lung lesions in Sjogren syndrome: analysis of lymphocyte subsets in tissue with clinico-radiologic-pathologic correlation Ann Diagn Pathol 2013 Feb;17(1):113-116. |
| Dugas HL, Peters JI, Robert O Williams III. Nebulization of Mycophenolate Mofetil Inhalation Suspension: Comparison with Oral and Pulmonary Administration of Cellcept International Journal of Pharmaceutics 2013 Jan;441(1-2):19-29. |
| H. Dugas, Peters JI, R.O. Williams III. Pulmonary Bioavailability of an Inhaled Mycophenolate Mofetil Suspension: Comparison with the Nebulization of IV Cellcept Solution Proceedings of the American Association of Pharmaceutical Scientists 2012 Oct;. |
| Burguete SR, Levine SM, Restrepo MI, Angel LF, Levine DJ, Coalson JJ, Peters JI. Lung transplantation for Williams-Campbell syndrome with a probable familial association Respir Care 2012 Sep;57(9):1505-1508. |
| Peters JI, Stupka JE, Singh H, Rossrucker J, Angel LF, Melo J, Levine SM. Status asthmaticus in the medical intensive care unit: A 30-year experience Respir Med 2012 Mar;106(3):344-348. |
| Burguete SR, Levine SM, Restrepo MI, Angel L, Levine DJ, Coalson JJ, Peters JI. A Role for Lung Transplantation in Williams-Campbell Syndrome Respiratory Care 2012 Jan;57(9):1505-1508. |
| H.L. Dugas, Peters JI, S.A. Stavchansky, R.O. Williams III. Hydrolysis of Mycophenolate Mofetil in Human Lung Epithelial Cells, Microsomes and Cyosol Fractions Biochemical Pharmacology (submitted) 2012 Jan;. |
| Peters JI, Stupka JE, Singh, Harjinder, Rossrucker, Jill, Angel L, Melo, Jairo, Levine SM. Status Asthmaticus in the Medical Intensive Care Unit: A Thirty Year Experience Respiratory Medicine 2012 Jan;106(3):344-348. |
| Peters JI, Anzueto AR. Azithromycin once daily for 1 year reduced acute COPD exacerbations Annals of Internal Medicine ACP Journal Club 2012 Jan;156(2):1-10. |
| Peters JI, Singh, H., Brooks EG, Diaz, J., Kannan TR, Coalson JJ, Baseman, J, Cagle, M., Baseman JB. Persistence of Community-Acquired Respiratory Distress Syndrome Toxin-Producing Mycoplasma pneumoniae in Refractory Asthma Chest 2011 Aug;140(2):401-407. |
| Watts AB, Peters JI, Talbert RL, ODonnell KP, Coalson JJ, Williams RO. Preclinical evaluation of tacrolimus colloidal dispersion for inhalation Eur J Pharm Biopharm 2011 Feb;77(2):207-215. |
| Peters JI, McKinney JM, Smith B, Wood P, Forkner E, Galbreath AD. Impact of obesity in asthma: evidence from a large prospective disease management study Ann Allergy Asthma Immunol 2011 Jan;106(1):30-35. |
| Yang W, Owens DE, Peters JI, Williams RO III. Improved Bioavailability of Engineered Amorphous Nanostructured Compositions of Poorly Water-Soluable Drugs by Rapid-Freezing Particle Engineering Technology Drug Delivery Technology 2010 Oct;10(8):22-31. |
| Watts AB, Cline AM, Saad AR, Johnson SB, Peters JI, Williams RO. Characterization and pharmacokinetic analysis of tacrolimus dispersion for nebulization in a lung transplanted rodent model Int J Pharm 2010 Jan;384(1-2):46-52. |
| Karpel JP, Peters JI, Szema AM, Smith B, Anderson PJ. Differences in physicians self-reported knowledge of, attitudes toward, and responses to the black box warning on long-acting beta-agonists Ann Allergy Asthma Immunol 2009 Oct;103(4):304-310. |
| Hardy, RD, Coalson JJ, Peters, JI, Chaparro, A, Techasaensiri, C, Cantwell AM, Kannan TR, Baseman JB, Dube PH. Analysis of Pulmonary Inflammation and Function in the Mouse and Baboon after Exposure to Mycoplasma pneumoniae CARDS Toxin Public Library of Science (PLoS ONE) 2009 Oct;4(10). |
| Tolman JA, Nelson NA, Bosselmann S, Peters JI, Coalson JJ, Wiederhold NP, Williams RO. Dose tolerability of chronically inhaled voriconazole solution in rodents Int J Pharm 2009 Sep;379(1):25-31. |
| Tolman JA, Wiederhold NP, McConville JT, Najvar LK, Bocanegra R, Peters JI, Coalson JJ, Graybill JR, Patterson TF, Williams RO. Inhaled voriconazole for prevention of invasive pulmonary aspergillosis Antimicrob Agents Chemother 2009 Jun;53(6):2613-2615. |
| Shelledy DC, LeGrand TS, Gardner DD, Peters JI. A Randomized, Controlled Study to Evaluate the Role of an In-Home Asthma Disease Management Program Provided by Respiratory Therapists in Improving Outcomes and Reducing the Cost of Care Journal of Asthma 2009 Mar;46:194-201. |
| Watts AB, Williams RO, Peters JI. Recent developments in drug delivery to prolong allograft survival in lung transplant patients Drug Dev Ind Pharm 2009 Mar;35(3):259-271. |
| Galbreath AD, Smith B, Wood PR, Inscore S, Forkner E, Vazquez M, Fallot A, Ellis R, Peters JI. Assessing the Value of Disease Management: impact of 2 disease management strategies in an underserved asthma population Ann Allergy Asthma Immunol 2008 Dec;101:599-607. |
| Tolman JA, Nelson NA, Son YJ, Bosselman S, Wiederhold NP,Peters JI, McConville JT, Williams III RO. Characterization and Pharmacokinetic Analysis of Aerosolized Aqueous Voriconazole Solution European Journal of Pharmaceutics and Biopharmaceutics 2008 Dec;:199-205. |
| Watts AB, Peters JI, Williams III RO. Recent Developments in Drug Delivery to Prolong Survival in Lung Transplant Patients Drug Development and Industrial Pharmacy 2008 Jun;34(9):913-922. |
| Galbreath AD, Smith B, Wood P, Forkner E, Peters JI. Cumulative recruitment experience in two large single-center randomized, controlled clinical trials Contemp Clin Trials 2008 May;29(3):335-342. |
| Yang W, Peters JI, Williams RO. Inhaled nanoparticles-A current review Int J Pharm 2008 May;356(1-2):239-247. |
| Overhoff KA, McConville JT, Yang W, Johnston KP, Peters JI, Williams RO. Effect of stabilizer on the maximum degree and extent of supersaturation and oral absorption of tacrolimus made by ultra-rapid freezing Pharm Res 2008 Jan;25(1):167-175. |
Book/Monograph |
| Peters JI, Shelledy, David, Editor and co- authored for four chapters. Textbook of Respiratory Care Burlington,Mass: Jones and Bartlet Learning; 2014. |
Book Chapter |
| Burguete SR, DeArmond DT, Peters JI. Pneumothorax (in press). In: Fishman AP, Elias JA, Fishman JA, Grippi MA, Kaiser LR, Senior RM. Fishman''s Pulmonary Diseases and Disorders, 5th edition (in press). NY: McGraw Hill; 2013. |
| Peters JI, Levine SM. Introduction to Pulmonary Function Testing, Chapter 32 (In press). In: Edited by J.T. DiPiro, R. L. Tabert, G.C Yee, G.R. Matzke, B.G Wells, L.M. Posey. Pharmacotherapy: A Pathophysiologic Approach. 2013. |
| Maselli DJ, Peters JI, Adams SG. Chapter 26: Hemoptysis. In: Editors: James F Shanahan and Robert Pancotti. The Patient History: An evidence-Based Approach to Differential Diagnosis. New York City, NY: McGraw-Hill Companies Inc; 2012. p. 251-257. |
| Peters JI. Introduction to Pulmonary Function Testing (Chapter 27). In: Peters, JI , Levine, Stephanie M. Respiratory Disorders. 2009. p. 271-278. |
| Levine DJ, Peters JI, Sako EY. Pneumothorax: Etiology, Diagnosis, and Treatment. In: Alfred Fishman, Jack Elias, Jay Fishman, Michael Grippi, Ropert Senior, Allan Pack. Fishmans Pulmonary Diseases and Disorders, McGraw Hill. 2008. p. 1517-1535. |
Abstract |
| Yi-Bo Wang, Alan B. Watts, Peters JI, Robert O. Williams III. The Impact of Pulmonary Diseases on the Fate of Inhaled Medicines; 2013 Nov. (International Journal of Pharmaceutics). |
| Bayer, J, Das NA, Baisden CE, Rani M, Schwacha MG, Sako EY, Williams, RO, Peters JI, Johnson SB. Effect of inhaled tacrolimus on ischemia reperfusion injury in rat lung transplant model: Minneapolis, MN; 2013 May. (The Journal of Thoracic and Cardiovascular Surgery; vol. 146, no. 5). |
| Watts, AB, Wang, Y, Carvalho, S, Peters JI, Williams, RO. A Comprehensive DPI Platform for Delivery of Small Molecules and Biologics; 2013 Jan. (American Thoracic International Conference Abstracts; vol. 276, no. A4114). |
| Alan B. Watts, Yi-Bo Wang, Levine SM, Peters JI, Robert O. Williams. Development of Inhaled Tacrolimus: Human Safety and Formulation Improvements; 2012 May. (Respiratory Drug Delivery 2012; vol. 3). |
| Peters JI. Impact of Omalizumab in Severe Asthmatics With Marked Elevation of IgE; 2011 Oct. (Chest; vol. 140, no. 4). |
| Levine SM, Singh H, Williams R, ODonnell K., Lang B, Wang Y, Anzueto AR, Talbert R., Peters JI. Safety and Tolerability of Single Dose Inhaled Tacrolimus in Healthy Subjects; 2011 Oct. (Chest Meeting Abstracts; vol. 140, no. 4). |
| Peters JI. Persistence of Mycoplasma pneumoniae (MP) in Patients With Refractory Asthma (RA); 2010 Oct. (Chest Meeting Abstracts; vol. 138, no. 4). |
| Vines DL, Sonetti D, Wettstein RB, Peters JI. A simple spontaneous breathing model used to evaluate oxygen mask performance; 2009 Oct. (Chest Meeting Abstracts). |
| Singh H, Peters JI, Morris M, Cagle M, Kannan TR, Baseman JG, Baseman JB. Distribution of a new serologic test for mycoplasma pneumoniae (MP) in a healthy population and a population presenting with acute exacerbation of asthma; 2009 Oct. (Chest Meeting Abstracts). |
| Peters JI, Singh H, Cagle M, Kannan TR, Baseman JB, Baseman, JG. Prevalence of mycoplasma pneumoniae infection in acute exacerbations of asthma in pediatric and adult population; 2009 Oct. (Chest Meeting Abstracts). |
| Levine DJ, Coalson JJ, Pollack MS, Werner S, Babu RV, Levine SM, Johnson SB, Peters JI, Calhoon JH, De Armond DT, Angel LF. Detection of HLA-II-DQ donor-specific antibody (DSA) in lung transplant recipients (LTRS) is associated with severe histopathologic changes and impaired graft survival even in the absence of other DSAS and positive C4D-immunostaining; 2009 Oct. (Chest Meeting Abstracts). |
| Peters JI, Singh H, Cagle M, Baseman JG, Baseman JB. Prevalence of Mycoplasma pneumoniae (MP) in Patients Hospitalized with Acute Exacerbation of Asthma (AEA); 2009 Apr. (Am. J. Respir. Crit. Care Med; vol. 179). |
| Peters JI, Gardner DD, Vines DL. Community aerosol device education study(CADE Study); 2008 Oct. (CHEST; vol. 134, no. s5500). |
| Saad AR, Cline AM, Watts AB, Hsiung GE, Peters JI, Baisden CE, Levine DJ, Calhoon JH, Angel LF, Williams III R, Johnson SB. Nanoparticle tacrolimus inhalation in rat lung transplant model; 2008 Oct. (CHEST; vol. 134, no. 4). |
| Sanchez J, Peters JI, Watts AB, Williams RB, Dube PH. Histological Changes in Ovalbumin Sensitized Mice Pretreated wtih Inhaled Cyclosporine; 2008 Oct. (CHEST; vol. 134). |
| Peters JI, Karpel JP, Szema AM, Smith B, Anderson P. Differences in physicians knowledge, attitudes and response to the black box warning on long-acting beta-agonists; 2008 Oct. (CHEST; vol. 134). |
| Peters JI, Watts A, Coalson J, Johnston K, Williams III R. Long-term safety of inhaled tacrolimus nanoparticles in rodent model; 2008 Oct. (CHEST; vol. 134). |
| Susanto IS, Sako EY, Anzueto AR, Levine SM, Peters JI, Cronin T, Jenkinson SG, Bryan C. Outcome of single lung transplants from the same donor: "Pulmonary Twinning"; 1995 Oct. (Chest; vol. 108, no. 3). |
Review Article |
| Yi-Bo Wang, Alan B. Watts, Peters JI, Robert O. Williams III. The Impact of Pulmonary Diseases on the Fate of Inhaled Medicines International Journal of Pharmaceutics 2013 Nov;. |
| Maselli DJ, Adams SG, Peters JI, Levine SM. Management of asthma during pregnancy Ther Adv Respir Dis 2013 Apr;7(2):87-100. |
| Maselli DJ, Adams S, Peters JI. The role of anti-infectives in the treatment of refractory asthma Ther Adv Respir Dis 2011 Dec;5(6):387-396. |
| Morales JO, Peters JI, Williams RO. Surfactants: their critical role in enhancing drug delivery to the lungs Ther Deliv 2011 May;2(5):623-641. |
| Carvalho TC, Peters JI, Williams RO. Influence of particle size on regional lung deposition--what evidence is there? Int J Pharm 2011 Mar;406(1-2):1-10. |
| Peters JI, Restrepo RD. Near-fatal asthma: recognition and management Current Opinion in Pulmonary Medicine 2008 Jan;14(1):24-30. |
Editorial |
| Maselli DJ, Peters JI. Five days of prednisone was noninferior to 14 days in patients with acute COPD exacerbation Ann Intern Med 2013 Sep;159(6):5-5. |
| Adams SG, Peters JI. Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPD Annals of Internal Medicine ACP Journal Club 2013 Mar;158(6):3-3. |
| Peters JI. Letter to Editor Chest Physician 2010 Mar;5(3). |
| Peters JI. Risks and Benefits of Long-acting Beta-agonists in Asthma. Evidence-Based Medicine for Primary Care and Internal Medicine American Journal of Medicine 2010 Jan;123:322-328. |
| Peters JI. Review: Formoterol increases serious adverse events in children and adults with chronic asthma Evid Based Med ACP Journal Club 2009 Jun;14(3):78-78. |
| Peters JI. Review: Systemic corticosteroids, antibiotics and noninvasive positive pressure ventilation are effective in acute COPD Annals of Internal Medicine ACP Journal Club 2008 Aug;149(2):13-13. |
Electronic/Web Publication |
| Peters JI. Case Studies in COPD: Therapy and Prevention of Exacerbations, Self Study Educational Module 2013 Sep. |
Not Specified |
| Adams SG, Peters JI. ACP Journal Club. Amoxicillin/clavulanate vs placebo: more exacerbation cures, fewer recurrences in mild-to-moderate COPD Ann Intern Med 2013 Mar;158(6):3-3. |
| Peters JI. Managing: Asthma Guidelines Pocketcard in association with the American College of Chest Physicians 2008 Jan;. |
Federal |
|
| Funding Agency | National Institute of Allergy and Infectious Disease (NIH) |
| Title | Mycoplasma Pneumoniae Infection in Patients with Chronic Asthma |
| Status | Active |
| Period | 8/2006 - 7/2013 |
| Role | Principal Investigator |
| Grant Detail | Dr. Peters funding is a subproject to Dr. Joel Basemans NIH Grant, Role of unique ADP-ribosylating vacuolating Mycoplasma pneumoniae toxin in asthma, Grant Number: U19AI070412. |
| Funding Agency | NIH |
| Title | Genetic Epidemiology of Chronic Obstructive Pulmonary Disease |
| Status | Active |
| Period | 9/2007 - 9/2012 |
| Role | Co-Investigator |
| Grant Detail | Genetic Epidemiology of Chronic Obstructive Pulmonary Disease. The original local grant was approximately $1.2 million. Renewal Pending- 7/1/2012-06/30/2017 |
| Funding Agency | National Institute of Allergy and Infectious Disease (NIH) |
| Title | Mycoplasma Pneumoniae Infection in a Pediatric Population - NIAID Supplemental Grant to Project 3 (Recovery and Reinvestment Act) |
| Status | Active |
| Period | 9/2009 - 9/2011 |
| Role | Principal Investigator |
| Grant Detail | Dr. Peters directs and oversees Co-investigators in the assessment of Mycoplasma in a pediatric population and the use of exhaled cindensates as a diagnostic tool. |
Private |
|
| Funding Agency | Merrell-Dow |
| Title | Use of Deflazocort in Chronic Asthma |
| Status | Active |
| Period | 10/1990 - Present |
| Role | Principal Investigator |
| Grant Detail | |
State |
|
| Funding Agency | State of Texas, Texas Ignition Grant |
| Title | Development of Nanoparticles of Inhaled Tacrolimus |
| Status | Active |
| Period | 7/2010 - 7/2014 |
| Role | Co-Principal Investigator |
| Grant Detail | Creation of nanoparticles of Tacrolimus for retreatment of chronic rejection. Creation of nanoparticles of Tacrolimus for the treatment of chronic rejection and asthma (patent pending). University of Texas Health Sciences Center at San Antonio and University of Texas School of Pharmacy. |
| Funding Agency | University of Texas Health Science Center, CTSA Grant |
| Title | Inhaled Tacrolimus in the Prevention of Rejection After Lung Transplantation |
| Status | Active |
| Period | 6/2011 - 6/2012 |
| Role | Co-Principal Investigator |
| Grant Detail | Evaluation of nanoparticles of Tacrolimus for the prevention of acute rejection in a rodent lung transplant model. |
| Funding Agency | University of Texas Health Science Center, CTSA Grant |
| Title | Inhaled Tacrolimus in the Prevention of Pulmonary Fibrosis |
| Status | Active |
| Period | 6/2011 - 6/2012 |
| Role | Co-Principal Investigator |
| Grant Detail | Evaluation of nanoparticles of Tacrolimus for the treatment of pulmonary fibrosis in a Bleomycin-induced injury model in rodents. |